Use of a phage display library to identify oligopeptides binding to the lumenal surface of polarized endothelium by ex vivo perfusion of human umbilical veins

Journal of Drug Targeting

Volumn 11, Issue 1, 2003, Pages 53-59

  Maruta, Fukuto ^a,b   Parker, Alan L ^a   Fisher, Kerry D ^a   Murray, Paul G ^a   Kerr, David J ^a,c   Seymour, Leonard W ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Oligopeptide; Phage display; Polarized vascular endothelium; Umbilical veins

Indexed keywords

COLLAGENASE; OLIGOPEPTIDE; PEPTIDE LIBRARY;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CELL ISOLATION; CELL STRAIN; CELL SURFACE; CONTROLLED STUDY; DRUG TARGETING; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NONHUMAN; PERFUSION; PHAGE DISPLAY; POLARIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN TARGETING; TISSUE SPECIFICITY; UMBILICAL CORD; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALS; BACTERIOPHAGES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MELANOMA, EXPERIMENTAL; MICE; OLIGOPEPTIDES; PEPTIDE LIBRARY; PERFUSION; PREGNANCY; PROTEIN BINDING; SEQUENCE ANALYSIS, PROTEIN; TUMOR CELLS, CULTURED; UMBILICAL VEINS;

EID: 0038746649     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1061186031000086063     Document Type: Article

References (27)

1. Arap, W., Pasqualini, R. and Ruoslahti, E. (1998) "Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model", Science 279, 377-380.
2. Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H.M., Bredesen, D.E., Pasqualini, R. and Ruoslahti, E. (2002a) "Targeting the prostate for destruction through a vascular address", Proc. Natl Acad. Sci. USA 99, 1527-1531.
3. Arap, W., Kolonin, M.G., Trepel, M., Lahdenranta, J., Cardo-Vila, M., Giordano, R.J., Mintz, P.J., Ardelt, P.U., Yao, V.J., Vidal, C.I., Chen, L., Flamm, A., Valtanen, H., Weavind, L.M., Hicks, M.E., Pollock, R.E., Botz, G.H., Bucana, C.D., Koivunen, E., Cahill, D., Troncoso, P., Baggerly, K.A., Pentz, R.D., Do, K.A., Logothetis, C.J. and Pasqualini, R. (2002b) "Steps toward mapping the human vasculature by phage display", Nat. Med. 8, 121-127.
4. Augustin, H.G., Kozian, D.H. and Johnson, R.C. (1994) "Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes", Bioessays 16, 901-906.
5. Ballinger, M.D., Shyamala, V., Forrest, L.D., Deuter-Reinhard, M., Doyle, L.V., Wang, J.X., Panganiban-Lustan, L., Stratton, J.R., Apell, G., Winter, J.A., Doyle, M.V., Rosenberg, S. and Kavanaugh, W.M. (1999) "Semirational design of a potent, artificial agonist of fibroblast growth factor receptors", Nat. Biotechnol. 17, 1199-1204.
6. Barry, M.A., Dower, W.J. and Johnston, S.A. (1996) "Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries", Nat. Med. 2, 299-305.
7. Binetruy-Tournaire, R., Demangel, C., Malavaud, B., Vassy, R., Rouyre, S., Kraemer, M., Plouet, J., Derbin, C., Perret, G. and Mazie, J.C. (2000) "Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis", EMBO J. 19, 1525-1533.
8. Fallaux, F.J., Kranenburg, O., Cramer, S.J., Houweling, A., Van Ormondt, H., Hoeben, R.C. and Van Der Eb, A.J. (1996) "Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors", Hum. Gene Ther. 7, 215-222.
9. Fisher, K.D., Ulbrich, K., Subr, V., Ward, C.M., Mautner, V., Blakey, D. and Seymour, L.W. (2000) "A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression", Gene Ther. 7, 1337-1343.
10. Fisher, K.D., Stallwood, Y., Green, N.K., Ulbrich, K., Mautner, V. and Seymour, L.W. (2001) "Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies", Gene Ther. 8, 341-348.
11. Folkman, J. and Shing, Y. (1992) "Angiogenesis", J. Biol. Chem. 267, 10931-10934.
12. Houston, P., Goodman, J., Lewis, A., Campbell, C.J. and Braddock, M. (2001) "Homing markers for atherosclerosis: applications for drug delivery, gene delivery and vascular imaging", FEBS Lett. 492, 73-77.
13. Larocca, D., Witte, A., Johnson, W., Pierce, G.F. and Baird, A. (1998) "Targeting bacteriophage to mammalian cell surface receptors for gene delivery", Hum. Gene Ther. 9, 2393-2399.
14. Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopoulos, N., Daly, T.J., Davis, S., Sato, T.N. and Yancopoulos, G.D. (1997) "Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis", Science 277, 55-60.
15. McConnell, S.J., Thon, V.J. and Spinella, D.G. (1999) "Isolation of fibroblast growth factor receptor binding sequences using evolved phage display libraries", Comb. Chem. High Throughput Screen. 2, 155-163.
16. Monaci, P., Urbanelli, L. and Fontana, L. (2001) "Phage as gene delivery vectors", Curr. Opin. Mol. Ther 3, 159-169.
17. Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltorak, Z. (1999) "Vascular endothelial growth factor (VEGF) and its receptors", FASEB J. 13, 9-22.
18. Nicklin, S.A., White, S.J., Watkins, S.J., Hawkins, R.E. and Baker, A.H. (2000) "Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display", Circulation 102, 231-237.
19. Odermatt, A., Audige, A., Frick, C., Vogt, B., Frey, B.M., Frey, F.J. and Mazzucchelli, L. (2001) "Identification of receptor ligands by screening phage-display peptide libraries ex vivo on microdissected kidney tubules", J. Am. Soc. Nephrol. 12, 308-316.
20. Pasqualini, R. and Ruoslahti, E. (1996) "Organ targeting in vivo using phage display peptide libraries", Nature 380, 364-366.
21. Poul, M.A. and Marks, J.D. (1999) "Targeted gene delivery to mammalian cells by filamentous bacteriophage", J. Mol. Biol. 288, 203-211.
22. Rajotte, D., Arap, W., Hagedorn, M., Koivunen, E., Pasqualini, R. and Ruoslahti, E. (1998) "Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display", J. Clin. Investig. 102, 430-437.
23. Seymour, L.W., Shoaibi, M.A., Martin, A., Ahmed, A., Elvin, P., Kerr, D.J. and Wakelam, M.J. (1996) "Vascular endothelial growth factor stimulates protein kinase C-dependent phospholipase D activity in endothelial cells", Lab. Investig. 75, 427-437.
24. Slopek, S., Weber-Dabrowska, B., Dabrowski, M. and Kucharewicz-Krukowska, A. (1987) "Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986", Arch. Immunol. Ther. Exp. 35, 569-583.
25. Walters, R.W., Grunst, T., Bergelson, J.M., Finberg, R.W., Welsh, M.J. and Zabner, J. (1999) "Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia", J. Biol. Chem. 274, 10219-10226.
26. White, S.J., Nicklin, S.A., Sawamura, T. and Baker, A.H. (2001) "Identification of peptides that target the endothelial cell-specific LOX-1 receptor", Hypertension 37, 449-455.
27. Zangani, D., Darcy, K.M., Masso-Welch, P.A., Bellamy, E.S., Desole, M.S. and Ip, M.M. (1999) "Multiple differentiation pathways of rat mammary stromal cells in vitro: acquisition of a fibroblast, adipocyte or endothelial phenotype is dependent on hormonal and extracellular matrix stimulation", Differentiation 64, 91-101.